Is Jasper Therapeutics Inc (JSPR) stock a buy?

The consensus among analysts is that Jasper Therapeutics Inc. (JSPR) is a Buy stock at the moment, with a recommendation rating of 1.50. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 5 have rated it as a Hold, with 5 advising it as a Buy. 0 have rated the stock as Underweight.

What is benchmark JSPR (JSPR)?

Benchmark is Select to analyze similar companies using key performance metrics; select up to 4 stocks. Find the latest Jasper Therapeutics, Inc. (JSPR) stock quote, history, news and other vital information to help you with your stock trading and investing.

Does NASDAQ use JSPR to determine compliance with listing requirements?

NASDAQ does not use this value to determine compliance with the listing requirements. Jasper Therapeutics, Inc. Common Stock (JSPR) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.